Terrie buys IDRA 2.75: Idera Pharmaceuticals and Collaborators Publish Promising Preclinical Data Targeting microRNA with Gene Silencing Oligonucleotid ...
CAMBRIDGE, Mass., Aug 06, 2014 (BUSINESS WIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) , a clinical-stage biopharmaceutical company developing nucleic acid therapeutics for patients with cancer and rare diseases, today announced the publication of ... ...
44 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home